Validity and reliability of patient reported outcomes used in Psoriasis: results from two randomized clinical trials

BACKGROUND: Two Phase III randomized controlled clinical trials were conducted to assess the efficacy, safety, and tolerability of weekly subcutaneous administration of efalizumab for the treatment of psoriasis. Patient reported measures of psoriasis-related functionality and health-related quality...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Shikiar, Richard, Bresnahan, Brian W, Stone, Stephen P, Thompson, Christine, Koo, John, Revicki, Dennis A
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2003
נושאים:
Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC269993/
https://ncbi.nlm.nih.gov/pubmed/14613569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7525-1-53
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים